124 related articles for article (PubMed ID: 10607872)
1. Endothelin receptor blockade attenuates air embolization-induced pulmonary hypertension in sheep.
Miyahara T; Koizumi T; Kubo K; Hanaoka M; Kaneki T; Yamamoto H; Ge RL; Fujimoto K; Kobayashi T; Shibamoto T
Eur J Pharmacol; 1999 Dec; 385(2-3):163-9. PubMed ID: 10607872
[TBL] [Abstract][Full Text] [Related]
2. Differential inhibition by TAK-044 of the inotropic effects of endothelin-1 and endothelin-3.
Yomogida S; Maruya J; Norota I; Ishii K; Endoh M
Eur J Pharmacol; 2004 May; 492(2-3):217-24. PubMed ID: 15178368
[TBL] [Abstract][Full Text] [Related]
3. Receptor binding and antagonist properties of a novel endothelin receptor antagonist, TAK-044 [cyclo[D-alpha-aspartyl-3-[(4-phenylpiperazin-1-yl) carbonyl]-L-alanyl-L-alpha-aspartyl-D-2-(2-thienyl) glycyl-L-leucyl-D-tryptophyl]disodium salt], in human endothelinA and endothelinB receptors.
Masuda Y; Sugo T; Kikuchi T; Kawata A; Satoh M; Fujisawa Y; Itoh Y; Wakimasu M; Ohtaki T
J Pharmacol Exp Ther; 1996 Nov; 279(2):675-85. PubMed ID: 8930171
[TBL] [Abstract][Full Text] [Related]
4. Renal effects of endothelin in anesthetized rabbits.
Ono N; Matsui T; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
Eur J Pharmacol; 1998 Oct; 359(2-3):177-84. PubMed ID: 9832389
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor antagonists in a beagle model of pulmonary hypertension: contribution to possible potential therapy?
Okada M; Yamashita C; Okada M; Okada K
J Am Coll Cardiol; 1995 Apr; 25(5):1213-7. PubMed ID: 7897136
[TBL] [Abstract][Full Text] [Related]
6. Ameliorating effect of an endothelin ETA receptor antagonist on renal function of DOCA-salt hypertensive rats.
Matsumura Y; Hashimoto N; Fujita K; Morimoto S
Eur J Pharmacol; 1997 Jan; 319(1):65-9. PubMed ID: 9030899
[TBL] [Abstract][Full Text] [Related]
7. Different contributions of the endothelin ET(A) receptor to hypertension induced by acute or chronic inhibition of nitric oxide synthesis.
Hashimoto N; Kuro T; Taira S; Matsumura Y
J Pharm Pharmacol; 1998 Sep; 50(9):1051-8. PubMed ID: 9811167
[TBL] [Abstract][Full Text] [Related]
8. Systemic, pulmonary, and renal hemodynamic effects of endothelin ET(A/B)-receptor blockade in patients with maintained left ventricular function.
Fleisch M; Sütsch G; Yan XW; Wenzel RR; Binggeli C; Bianchetti MG; Meier B; Kiowski W; Lüscher TF
J Cardiovasc Pharmacol; 2000 Sep; 36(3):302-9. PubMed ID: 10975586
[TBL] [Abstract][Full Text] [Related]
9. Effects of a new endothelin receptor antagonist, TAK-044, on myocardial stunning in dogs.
Kitayoshi T; Ikeda S; Kubo K; Awane-Igata Y; Watanabe T; Fujino M
Eur J Pharmacol; 1996 Jun; 305(1-3):137-43. PubMed ID: 8813544
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of cardiovascular responses induced by endothelin-1 in the perfused rat heart.
Kusumoto K; Fujiwara A; Ikeda S; Watanabe T; Fujino M
Eur J Pharmacol; 1996 Jan; 296(1):65-74. PubMed ID: 8720478
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte depletion attenuates sustained pulmonary hypertension and increased pulmonary vasoreactivity caused by continuous air embolization in sheep.
Perkett EA; Brigham KL; Meyrick B
Am Rev Respir Dis; 1990 Feb; 141(2):456-65. PubMed ID: 2301860
[TBL] [Abstract][Full Text] [Related]
12. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
[TBL] [Abstract][Full Text] [Related]
13. Continuous air embolization into sheep causes sustained pulmonary hypertension and increased pulmonary vasoreactivity.
Perkett EA; Brigham KL; Meyrick B
Am J Pathol; 1988 Sep; 132(3):444-54. PubMed ID: 3414777
[TBL] [Abstract][Full Text] [Related]
14. Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.
Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
Eur J Pharmacol; 1995 Jul; 280(3):311-6. PubMed ID: 8566099
[TBL] [Abstract][Full Text] [Related]
15. Potentiation by endothelin-1 of vasoconstrictor response in stroke-prone spontaneously hypertensive rats.
Matsumura Y; Kita S; Okui T
Eur J Pharmacol; 2001 Mar; 415(1):45-9. PubMed ID: 11245851
[TBL] [Abstract][Full Text] [Related]
16. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.
Ivy DD; Kinsella JP; Abman SH
J Clin Invest; 1994 May; 93(5):2141-8. PubMed ID: 8182146
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of 3-azabicyclo[3,2,1] octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel ET(A) receptor-selective antagonist.
Li X; Liu KL; Zheng JQ; Chi MG; Dong JJ; Dong SJ; Gong ZH
Pulm Pharmacol Ther; 2008 Oct; 21(5):780-7. PubMed ID: 18602014
[TBL] [Abstract][Full Text] [Related]
18. Facilitation and inhibition by endothelin-1 of adrenal catecholamine secretion in anesthetized dogs.
Hosokawa A; Nagayama T; Yoshida M; Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
Eur J Pharmacol; 2000 May; 397(1):55-61. PubMed ID: 10844099
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-A receptor blockade in porcine pulmonary hypertension.
Ambalavanan N; Philips JB; Bulger A; Oparil S; Chen YF
Pediatr Res; 2002 Dec; 52(6):913-21. PubMed ID: 12438670
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the role of endothelin-A and endothelin-B receptors on nociceptive information transmission in the spinal cord with FR139317, an endothelin-A receptor antagonist, and sarafotoxin S6c, an endothelin-B receptor agonist.
Yamamoto T; Shimoyama N; Asano H; Mizuguchi T
J Pharmacol Exp Ther; 1994 Oct; 271(1):156-63. PubMed ID: 7965709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
